Al-Aly explained that the use of GLP-1s has soared in the last couple years while multiple studies have captured their far-reaching benefits, but [we] realized that no one has comprehensively investigated the effectiveness and risks of GLP-1 receptor agonists across all possible health outcomes. In the study, Al-Aly and colleagues mapped out associations between GLP-1s and 175 possible health outcomes by comparing a cohort of people with diabetes who used the treatments (n = 215,970) with: those who used sulfonylureas (n = 159,465)
Therefore, the prevalence of GLP-1 RAs users was 4.5% (7,511 of 165,860)
Journal of Strength and Conditioning Research 28(2):514519
Enhances Skin Health and Anti-Aging Glutathione is well-known for its ability to brighten skin, reduce hyperpigmentation, and slow down aging by protecting against oxidative damage
"Efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5)"
Individual results vary based on training load, genetics, and adherence to protocols